Share
))
HBO and The Ringer's Bill Simmons hosts the most downloaded sports podcast of all time, with a rotating crew of celebrities, athletes, and media staples, as well as mainstays like Cousin Sal, Joe House, and a slew of other friends and family members who always happen to be suspiciously available.
…
continue reading
Manage episode 515682015 series 3609475
Content provided by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Article source: https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/rsv-vaccine-older-adults-92-protective-against-poor-outcomes-real
The provided text, originating from the University of Minnesota's Center for Infectious Disease Research & Policy (CIDRAP), primarily offers an overview of a real-world study estimating the effectiveness of the RSVpreF (Abrysvo) vaccine in adults aged 60 and older.
The study found the vaccine to be 92% effective against severe outcomes like emergency department visits or hospitalizations for respiratory illness, with effectiveness rising to 95% in those aged 75 and older.
It notes that this level of protection is higher than other current respiratory vaccines and suggests continued evaluation is needed, especially with pending recommendations for younger adults; however, it also reports that the uptake of the vaccine has been low.
Additionally, the source includes a section on related infectious disease news and information about CIDRAP, including its underwriters and contact details.
102 episodes
